Cite
HARVARD Citation
Vugmeyster, Y. et al. (2020). Selection of the Recommended Phase 2 Dose for Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF‐β and PD‐L1. Clinical pharmacology & therapeutics. 108 (3), pp. 566-574. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vugmeyster, Y. et al. (2020). Selection of the Recommended Phase 2 Dose for Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF‐β and PD‐L1. Clinical pharmacology & therapeutics. 108 (3), pp. 566-574. [Online].